Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704336 | SCV000528230 | likely benign | not provided | 2021-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000475026 | SCV000557807 | likely benign | Primary dilated cardiomyopathy | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621733 | SCV000737254 | likely benign | Cardiovascular phenotype | 2017-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001704336 | SCV005208964 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001704336 | SCV001978484 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001704336 | SCV001980143 | likely benign | not provided | no assertion criteria provided | clinical testing |